News
-
Sorrento Therapeutics said that the FDA has cleared its IND for a Phase 1 study of STI-2099 intranasal neutralizing antibody (CoviDrops) in healthy volunteers and in patients with mild COVID-19. The company said that it… Read more . . .
-
According to Oyster Point Pharma, the FDA has accepted the company’s NDA for its OC-01 varenicline nasal spray for the treatment of dry eye disease and has set a PDUFA goal date of October 17,… Read more . . .
-
Cipla Limited announced that the FDA has issued final approval of an ANDA for the company’s generic version of GSK’s Imitrex 20 mg sumatriptan nasal spray. Cipla’s sumatriptan nasal spray is an AB-rated generic. Imitrex… Read more . . .
-
Impel NeuroPharma has named Leonard S. Paolillo as Chief Commercial Officer and Gerald F. Penn as VP, Market Access and Trade in anticipation of the launch of Trudhesa intranasal dihydroergotamine mesylate (DHE) for the treatment… Read more . . .
-
OINDP testing specialist Copley Scientific has announced upgrades to the company’s inhaler testing equipment range, including new products such as the Inhaler Testing Workstation (ITW) and updates to its TPK critical flow controllers, BAC 2100 breath… Read more . . .
-
Atossa Therapeutics announced that a two-week Phase 1 study evaluating the safety of two dose levels of the company’s AT-301 nasal spray in healthy volunteers demonstrated that the nasal spray was safe and well tolerated.… Read more . . .
-
Reflections by Philip Kuehl and Jacob McDonald, Lovelace Biomedical What a year! 2020 was the year when those of us in aerosol science were forced to stop compartmentalizing. It was the year that we could… Read more . . .
-
Virpax Pharmaceuticals said that the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health has begun pre-clinical studies of Virpax’s Envelta intranasal enkephalin to support an IND submission. Virpax signed a cooperative… Read more . . .
-
Starpharma said that it is set to launch its Viraleze astodrimer sodium antiviral nasal spray within the next month after receiving approval to market the nasal spray in Europe and the UK. In September 2020,… Read more . . .
-
Aridis Pharmaceuticals announced that it is now receiving preclinical support from the NIAID (National Institute of Allergy and Infectious Diseases) and CoVIC (Coronavirus Immunotherapy Consortium) for a nebulized monoclonal antibody cocktail for COVID-19 and that… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland